"How late is too late?" is one of the most common questions families ask after a loved one is diagnosed with a large vessel occlusion stroke. The thrombectomy time window refers to the period after symptom onset during which mechanical clot removal may still be considered, and it is longer than many people expect. While earlier treatment is generally associated with better outcomes, appropriately selected patients may still be considered for treatment up to 24 hours after symptoms began, based on brain imaging rather than the clock alone. This article explains, in general educational terms, how that window is defined and assessed.
Why Is "Time Is Brain" a Guiding Principle?
"Time is brain" is a phrase commonly used in stroke care to communicate that brain tissue is lost progressively for as long as blood flow remains blocked. This is why stroke symptoms such as sudden weakness, facial drooping, or speech difficulty are widely recognized as warning signs that warrant an immediate call to emergency services. Faster recognition and transport to a stroke-capable hospital generally allow more time for evaluation and treatment options, including mechanical thrombectomy, before a decision must be made.
What Defines the Early Time Window?
The early thrombectomy time window is generally described as up to approximately 6 hours from the last time a patient was known to be well. Within this period, treatment decisions have traditionally relied more heavily on the time elapsed and standard imaging such as a non-contrast CT scan to rule out bleeding and assess early tissue changes. Patients presenting within this window are commonly evaluated quickly, since earlier intervention is generally associated with a greater likelihood of preserving brain tissue that is still at risk but not yet permanently damaged.
How Does Late Window Thrombectomy Selection Work?
Late window thrombectomy refers to treatment considered between approximately 6 and 24 hours after symptom onset, or after a patient was last known well. Because more time has passed, physicians rely more heavily on advanced imaging selection to determine whether treatment may still offer benefit. This typically involves techniques such as CT perfusion or MRI, which help estimate how much brain tissue has already been permanently affected (the infarct core) versus how much tissue is still at risk but potentially salvageable (the penumbra). Patients with a comparatively small core of permanent damage relative to a larger area of at-risk tissue may be considered candidates for late window treatment, while others may not be. This determination is made on a case-by-case basis by a qualified physician using established imaging criteria.
What Role Does Imaging Selection Play Beyond the Time Window?
Imaging selection is not only used to extend eligibility into later hours; it is also used throughout the time window to confirm the location of a large vessel occlusion, assess collateral blood flow, and rule out conditions that would make thrombectomy inappropriate, such as significant existing hemorrhage. This imaging-based approach reflects a broader shift in stroke care toward individualized decision-making rather than relying on elapsed time alone. Devices used during the procedure itself, such as stent retrievers within INVAMED's neurovascular interventions category, are applied only after this selection process has identified an appropriate candidate.
Why does "last known well" matter more than exact symptom onset in some cases?
Stroke symptoms are not always witnessed, so clinicians often use the last time a person was confirmed to be normal as the reference point for calculating the time window. This is a standard, conservative approach used to guide imaging-based eligibility assessments.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.